Pacific Biosciences of California, Inc.
PACB
$1.38
$0.129.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.81% | -445.01% | 102.89% | 9.19% | -148.19% |
| Total Depreciation and Amortization | -67.93% | 3,002.87% | -6.41% | 195.12% | 193.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.34% | -26.55% | -355.31% | 86.12% | 493.43% |
| Change in Net Operating Assets | 38.84% | 90.58% | 208.10% | -37.10% | -240.43% |
| Cash from Operations | 45.86% | 41.79% | 46.75% | 30.25% | -30.00% |
| Capital Expenditure | 62.81% | 64.19% | 20.11% | 194.82% | 34.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -67.01% | 254.09% | 192.73% | -90.84% | 181.31% |
| Cash from Investing | -67.10% | 232.51% | 187.48% | -90.48% | 177.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -11,180.90% | 100.00% | 67.31% |
| Issuance of Common Stock | -- | -71.57% | -100.00% | -82.20% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 38.85% | -- | -- |
| Cash from Financing | 100.00% | -70.11% | 38.48% | 203.97% | 96.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.26% | 103.04% | 89.01% | -112.24% | 115.46% |